On Thursday, MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) announced the formulation of Ketamir-2 as a topical treatment for localized neuropathic and inflammatory pain. The advancement expands the ...
CARLSBAD, Calif.--(BUSINESS WIRE)--BriOri BioTech, an emerging pre-clinical stage biotech company focused on developing a pipeline of opiate-free topical pain medications, announces its patent for ...
Phase 3 development to consist of single pivotal trial Previously reported data demonstrated that roflumilast foam provided statistically significant improvement and a favorable safety and ...
BOSTON--(BUSINESS WIRE)--DermBiont, a clinical-stage biotechnology company developing targeted topical therapeutics that address the root causes of skin diseases, announced today that it has raised a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback